SENTRY Research Study

Ovarian cancer is often diagnosed at later stages, contributing to its high mortality rates. Our study seeks to find early diagnostic markers by examining changes in blood platelets. Early detection could significantly improve survival rates.

Your participation will contribute to critical research that may improve early ovarian cancer diagnosis.

What is the purpose of this study?

• Determine if changes in platelets can help diagnose ovarian cancer earlier
• Explore if platelet changes can distinguish between benign and cancerous ovarian masses before surgery

Who can participate?

We are currently recruiting three groups of participants:

• Women over the age of 21 with a recent diagnosis of an ovarian or pelvic mass
• Control women over the age of 21 without ovarian cancer or an ovarian mass

Certain conditions or previous treatments may exclude participants. Please reach out for details. Contact our study coordinator at 801-585-0161 for more information and to find out if you're eligible.

Where can I participate?

Your visit can take place at a regular appointment or at Huntsman Cancer Institute.

What should I expect?

A one-time study visit, coordinated with your regular clinic appointments at the Huntsman Cancer Institute. The visit will last approximately 30 minutes and involve a small blood draw.